K-numberK244008
Device nameSpectral CT
ApplicantPhilips Medical Systems Technologies , Ltd.
Product codeJAK
Device classClass II
Decision dateMay 16, 2025
DecisionSubstantially Equivalent
Regulation892.1750
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Spectral CT system is a computed tomography X-ray system that produces cross-sectional images of the body by computer reconstruction of X-ray transmission data. It acquires dual-energy spectral data (higher and lower energy X-ray spectra) to analyze material composition and generate images at selected energies, providing information about chemical composition, attenuation, material density, and effective atomic number. It is indicated for head, whole body, cardiac, and vascular CT applications in patients of all ages, including low-dose lung cancer screening, diagnostic radiology, interventional radiology, cardiology, and radiation therapy planning.

Technological characteristics

The proposed device shares identical fundamental design and technology with the primary predicate (K203020) including: 128 slices of 0.625mm, continuous rotation gantry, 800mm bore, identical spatial resolution (16 lp/cm high mode), dual-layer scintillator detectors, and identical generator/tube specifications (120kW, 80-140 kV). New features include: Extended Field of View (EFOV) up to 800mm for non-gated helical scans (identical to secondary predicate K240844) and Pulmonary Gating 4DCT for radiation therapy planning (also from K240844). All other specifications including scan modes, couch parameters, and reconstruction methods remain identical.

Test standards cited

IEC 60601-1:2005 A1:2012 A2:2020 (general safety), IEC 60601-1-2:2014 A1:2020 (EMC), IEC 60601-1-3:2008 A2:2021 (radiation protection), IEC 60601-1-6:2010 (usability), IEC 60601-2-28:2017 (X-ray tube assemblies), IEC 60601-2-44:2009 A1:2012 A2:2016 (CT equipment), IEC 62304:2006 (software lifecycle), ISO 14971:2019 (risk management), and ISO 10993-1:2018 (biocompatibility). Design verification and validation testing demonstrated compliance with system requirements specifications.

Substantial equivalence argument

The proposed device is substantially equivalent because it shares identical fundamental scientific technology and design with the primary predicate K203020 across all core specifications (detector type, gantry design, image matrix, spatial resolution, noise performance). The two new features—Extended Field of View and Pulmonary Gating 4DCT—are directly borrowed from the already-cleared secondary predicate K240844 and raise no new safety or effectiveness concerns. Non-clinical testing including phantom-based image quality assessment and clinical image evaluation confirmed performance is equivalent to predicates. The minor design differences do not alter the intended use, principles of operation, or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →